Furthermore, plasma DPP4 activity progressively increased with the number of metabolic syndrome components developed by study participants over follow-up whereas active GLP-1 decreased progressively (P for trend <0.001 in both men and women) (Table 2). The gene discussed is DPP4; the disease is metabolic syndrome.